Cochlear Limited (ASX:COH – Get Free Report) insider Christine McLoughlin purchased 200 shares of the firm’s stock in a transaction on Friday, February 28th. The shares were acquired at an average price of A$261.73 ($162.57) per share, for a total transaction of A$52,346.00 ($32,513.04).
Cochlear Price Performance
The company has a current ratio of 2.30, a quick ratio of 1.93 and a debt-to-equity ratio of 13.24. The company has a market cap of $19.88 billion, a P/E ratio of 55.90, a price-to-earnings-growth ratio of 3.87 and a beta of 0.47.
Cochlear Increases Dividend
The company also recently declared a Interim dividend, which will be paid on Sunday, April 13th. Investors of record on Sunday, April 13th will be issued a dividend of $2.15 per share. This is an increase from Cochlear’s previous Interim dividend of $2.00. This represents a yield of 0.78%. The ex-dividend date of this dividend is Wednesday, March 19th. Cochlear’s dividend payout ratio (DPR) is currently 77.35%.
About Cochlear
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than Cochlear
- What is a Special Dividend?
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
- 3 Stocks to Consider Buying in October
- Zoom Stock: Leading the Video Market After Skype’s Exit
- How to Invest in Blue Chip Stocks
- Intuitive Machines: March 6 Is a Pivotal Day for Lunar Economy
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
